Clinical Trials

Leukemia, Lymphocytic, Chronic, B-Cell

NCT04883749 2025-06-08

CLL-Frail

53 enrolled

Leukemia, B-Cell

NCT04402138 2025-05-13

Treatment With Acalabrutinib Post Blood or Marrow Transplantation in Subjects With Mantle Cell Lymphoma

15 enrolled 10 charts

Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell

NCT04630756 2025-04-09

AZD4573 in Novel Combinations With Anti-cancer Agents in Patients With Advanced Blood Cancer

Phase 1/2 Completed

40 enrolled 31 charts

Advanced Haematological Malignancies

NCT03787264 2024-12-30

CLL2-BAAG

46 enrolled

Leukemia, B-Cell

NCT02112526 2024-12-20

Acalabrutinib (ACP-196), a Btk Inhibitor, for Treatment of de Novo Activated B-cell (ABC) Subtype of Diffuse Large B-Cell Lymphoma

21 enrolled 11 charts

Immune System Diseases, Immunoproliferative Disorders, Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT04930536 2024-11-22

Acalabrutinib Study in Indian Patients With Chronic Lymphocytic Leukaemia & Relapsed and Refractory Mantle Cell Lymphoma

Phase 4 Completed

103 enrolled 10 charts

Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Mantle-Cell

NCT03788291 2024-09-26

Acalabrutinib and High Frequency Low Dose Subcutaneous Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma

39 enrolled 8 charts

Leukemia, Lymphocytic, Chronic, B-Cell

NCT03571308 2023-09-28

ACCEPT

Phase 1/2 Completed

39 enrolled

Lymphoma, Non-Hodgkin

NCT03527147 2022-08-15

PRISM

30 enrolled

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT04564040 2020-12-29

A Study in Healthy Subjects to Assess Bioavailability (Proportion of a Drug Which Enters the Circulation to Have an Active Effect) of Acalabrutinib Tablet and Protonpump Inhibitor Effect (Members of a Class of Medications That Inhibits in Gastric Acid Production) for Rabeprazole

20 enrolled

COVID-19, Lymphoma, Mantle-Cell

NCT02211014 2020-07-31

An Open-Label, Phase 1b Study of Acalabrutinib With and Without Dexamethasone in Subjects With Multiple Myeloma

27 enrolled 13 charts

Plasma cell

Multiple Myeloma

NCT02362048 2019-10-01

KEYNOTE144

77 enrolled 11 charts

Gastrointestinal

Pancreatic Neoplasms

NCT02537444 2019-09-25

Acalabrutinib (ACP-196) Alone and in Combination With Pembrolizumab in Ovarian Cancer (KEYNOTE191)

78 enrolled 10 charts

Gynecologic

Ovarian Neoplasms

NCT02448303 2019-09-12

KEYNOTE166

74 enrolled 10 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02454179 2019-09-12

KEYNOTE147

78 enrolled 10 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT02351739 2019-09-10

KEYNOTE143